Lower riskDrug recall · FDA · Published September 16, 2016
Hospira Marcaine 0.25% Injection Recall: Risk of Lower Potency Due to Glass Defect
Hospira recalls Marcaine 0.25% injections with a glass defect that may cause the product to be less potent than labeled. Affected lots were sold in 2017. Consumers should contact Hospira for details.
Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.
Take action
Contact the company
📍Recalling firmHospira Inc., A Pfizer Company275 N Field Dr · Lake Forest, IL 60045-2579
“Hospira Marcaine 0.25% Injection Recall: Risk of Lower Potency Due to Glass Defect.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42437-hospira-marcaine-0-25-injection-recall-risk-of-lower-potency. Based on FDA recall #D-0096-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0096-2017%22&limit=1).
The FDA announced on Sept. 16, 2016, that Hospira Inc., a Pfizer company, voluntarily recalled Marcaine 0.25% injection due to sterility and subpotency risks. The recall affects 15 vials distributed nationwide and in Puerto Rico.
How to tell if you have it
Brand: Hospira
Product: Marcaine 0.25% (bupivacaine HCl) injection, USP, 125 mg/50 mL (2.5 mg/mL), 50 mL Multiple-Dose Vial
NDC: 0409-1587-50
Lot #: 60295DD
Expiration Date: Ep 1DEC2017
The hazard
A defect in the glass vial prevented the stopper from forming a seal, allowing water to ingress and dilute the product. This resulted in a lack of assurance of sterility and a subpotent drug that is less than the labeled potency.
Context
GovInfoNow's records show Hospira Inc. A Pfizer Company has six other recalls on record since Aug. 4, 2016. Other recent recalls include a Feb. 20, 2018 recall for cracked vial risk and a July 6, 2017 recall for impurities risk. Similar products recalled recently include Somerset Therapeutics Cisatracurium Besylate Injection on Nov. 26, 2025, and Keystone DHP Topical Anesthetic Gel on May 21, 2026.
How to tell if you have this one
Check for the product name 'Marcaine 0.25% (bupivacaine HCl) injection, USP, 125 mg/50 mL (2.5 mg/mL), 50 mL Multiple-Dose Vial'. The lot number 60295DD was produced in December 2017.
Brand
Hospira
Category
Drug
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Marcaine 0.25% (bupivacaine HCl) injection, USP, 125 mg/50 mL (2.5 mg/mL), 50 mL Multiple-Dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1587-50.; Lot #: 60295DD, Ep 1DEC2017
15 vials
D-0097-2017
Marcaine 0.5% (bupivacaine HCl) injection, USP, 250 mg/50 mL (5 mg/mL), 50 mL Multiple-Dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1610-50.; Lot #: 59310DD, Exp 1NOV2017
4768 vials
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the lot number 60295DD on the vial label, which was produced in December 2017.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.9 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0096-2017 (September 16, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0096-2017 to see it in context.
Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.